Zeltia , posible entrada de inversores extranjeros antes publicarse los resultados del Yondelis en Ovario .

Zeltia could be in focus after the rumour column in the weekend edition of La Gaceta noted foreign investors could be buying shares in the pharmaceutical company ahead of approval for a new Yondelis drug.